DermTech 2. 0 | Rule Out Melanoma with Precision Genomics DermTech 2 0 is a platform technology company that provides genomic analysis of skin samples collected non-invasively using its proprietary Smart Sticker ® DermTech 2 0 develops and markets products, including the DermTech Melanoma Test, to facilitate the assessment of melanoma and other skin diseases, and offers DermTech Stratum, precision biomarker services for biopharmaceutical and
Non-invasive skin sample collection: Comparing D-squame and . . . - DermTech Methods Collection of stratum corneum via tape stripping is a minimally invasive procedure applied in a number of fields, including identification of epidermal biomarkers in skin cancers and inflammatory disorders Tape stripping is an established technique; however, the number and types of tapes used in different studies vary widely As an example, the most commonly used tape, D-squame skin
DermTech Melanoma Test | DermTech 2. 0 Get the details on how the DermTech Melanoma Test noninvasively detects genomic markers associated with melanoma, as well as incorporating it into your practice
Leadership | DermTech 2. 0 Jeremy Teraoka, is the Head of Finance at DermTech, LLC Mr Teraoka is a seasoned finance and operations executive with extensive investment banking and biotech experience across North America, Asia and Europe Trained in the UK with KPMG, Mr Teraoka has held CFO, Finance Director, and Controller positions, working in both multinational corporations and fast-growing startups As a co-founder
News Media - DermTech 2. 0 DermTech 2 0 in the News Read how DermTech 2 0 is changing the world of dermatology
DermTech: Rule Out Melanoma with Precision Genomics @DermTech Instructions For Use DermTech Adhesive Skin Biopsy Kit Client Services: 1 866 450 4223 DermTech com The DermTech Adhesive Skin Biopsy Kit contains all necessary materials to non-invasively collect and mail a skin sample to the DermTech Laboratory for rmlecular pathology gene expression analysis The steps involved in this procedure reserved for licensed providers are very similar to
Microsoft Word - DermTech Secures Billing Codes for its Proprietary . . . DermTech Secures Billing Codes for its Proprietary Melanoma Test LA JOLLA, CA (July 13, 2017) – DermTech, Inc , the global leader in non-invasive molecular dermatology, reported today that the American Medical Association (AMA) has granted the company Category 1, Tier 2 Molecular Pathology procedure codes related to its proprietary test for the detection of melanoma related gene expression
Physician Resources | DermTech 2. 0 We’re more than a lab We’re your precision genomics partner Add DermTech 2 0 to your practice and advance your patient care
Contact Us | DermTech 2. 0 The DermTech Melanoma Test® is a non-invasive genomic test utilizing DermTech Smart Stickers® to assess equivocal melanocytic lesions meeting one or more of the